LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMFA01031343
|
Patroneic acid
|
20Z-triacontenoic acid
|
FA 30:1
|
C30H58O2 |
450.443680
|
LMFA01031344
|
Lavoisieric acid
|
25Z-triacontenoic acid
|
FA 30:1
|
C30H58O2 |
450.443680
|
LMFA01031345
|
Orbonaic acid
|
5Z,8Z-nonadecadienoic acid
|
FA 19:2
|
C19H34O2 |
294.255880
|
LMFA01031346
|
Verniceic acid
|
10Z,13Z-eicosadienoic acid
|
FA 20:2
|
C20H36O2 |
308.271530
|
LMFA01031347
|
Dermateic acid
|
7Z,10Z-eicosadienoic acid
|
FA 20:2
|
C20H36O2 |
308.271530
|
LMFA01031348
|
Meanjinic acid
|
5Z,8Z-eicosadienoic acid
|
FA 20:2
|
C20H36O2 |
308.271530
|
LMFA01031349
|
Feteic acid
|
12Z,15Z-eicosadienoic acid
|
FA 22:2
|
C22H40O2 |
336.302830
|
LMFA01031350
|
Prenateic acid
|
14Z,17Z-tetracosadienoic acid
|
FA 24:2
|
C24H44O2 |
364.334130
|
LMFA01031351
|
Nativitatic acid
|
16Z,19Z-hexacosadienoic acid
|
FA 26:2
|
C26H48O2 |
392.365430
|
LMFA01031352
|
Progigneic acid
|
20Z,23Z-triacontadienoic acid
|
FA 30:2
|
C30H56O2 |
448.428030
|
LMFA01031353
|
5Z,8Z,11Z-octadecatrienoic acid
|
5Z,8Z,11Z-octadecatrienoic acid
|
FA 18:3
|
C18H30O2 |
278.224580
|
LMFA01031354
|
9Z,15Z,18Z,21Z-tetracosatetraenoic acid
|
9Z,15Z,18Z,21Z-tetracosatetraenoic acid
|
FA 24:4
|
C24H40O2 |
360.302830
|
LMFA01031355
|
Bergstromic acid
|
12Z,15Z,18Z,21Z-tetracosatetraenoic acid
|
FA 24:4
|
C24H40O2 |
360.302830
|
LMFA01031356
|
Samuelssonic acid
|
9Z,12Z,15Z-tetracosatrienoic acid
|
FA 24:3
|
C24H42O2 |
362.318480
|
LMFA01031357
|
Vaneic acid
|
9Z,12Z,15Z-docosatrienoic acid
|
FA 22:3
|
C22H38O2 |
334.287180
|
LMFA01031358
|
Capecchic acid
|
11Z-heneicosenoic acid
|
FA 21:1
|
C21H40O2 |
324.302830
|
LMFA01031359
|
Coreynic acid
|
5Z,8Z,11Z-nonadecatrienoic acid
|
FA 19:3
|
C19H32O2 |
292.240230
|
LMFA01031360
|
Yamanakanic acid
|
7Z,10Z,13Z-heneicosatrienoic acid
|
FA 21:3
|
C21H36O2 |
320.271530
|
LMFA01140109
|
Tripmycin A
|
13-(2-methylphenyl)-12E-tridecenoic acid
|
FA 20:5
|
C20H30O2 |
302.224580
|
LMFA01140110
| |
5-(2-Methylphenyl)-4-pentenoic acid
|
FA 12:5
|
C12H14O2 |
190.099380
|
LMFA01031363
|
Dinheic acid
|
5Z,8Z,15Z-octadecatrienoic acid
|
FA 18:3
|
C18H30O2 |
278.224580
|
LMFA01031362
|
Foigeic acid
|
8Z,15Z-octadecadienoic acid
|
FA 18:2
|
C18H32O2 |
280.240230
|
LMFA01031361
|
Menzeleic acid
|
6Z,13Z-hexadecadienoic acid
|
FA 16:2
|
C16H28O2 |
252.208930
|
LMFA01050603
|
20-HEPE
|
(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic acid
|
FA 20:5;O
|
C20H30O3 |
318.219495
|
LMFA01050604
|
22-HDHA
|
22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3 |
344.235145
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5 |
385.282824
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5 |
357.251524
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4 |
395.303559
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4 |
367.272259
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4 |
339.240959
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4 |
423.334859
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4 |
397.319209
|
LMFA07070127
|
2E,7Z-Hexadecadienoylcarnitine
|
3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4 |
395.303559
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5 |
413.314124
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5 |
385.282824
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4 |
367.272259
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4 |
313.225309
|
LMFA07070133
|
3S-hydroxyoctanoylcarnitine
|
3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 8:0;O
|
C15H29NO5 |
303.204574
|
LMFA07070132
|
3S-hydroxydecanoylcarnitine
|
3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 10:0;O
|
C17H33NO5 |
331.235874
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5 |
415.329774
|
LMFA02000412
|
13S-HOME(9Z)
|
13S-hydroxy-9Z-octadecenoic acid
|
FA 18:1;O
|
C18H34O3 |
298.250795
|
LMFA03050032
|
11,12,15-THETA
|
11,12,15-trihydroxy-5Z,8Z,13E-eicosatrienoic acid
|
FA 20:3;O3
|
C20H34O5 |
354.240625
|
LMFA02030075
|
Callicarboric acid A
|
Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate
|
FA 19:5;O2
|
C19H28O4 |
320.198760
|
LMFA02030076
|
Callicarboric acid B
|
Methyl (1S,2R)-4-oxo-5-(methyl acetoyl)-2-cyclopentene-1-octanoate
|
FA 17:4;O3
|
C17H26O5 |
310.178025
|
LMFA01020445
| |
(Z)-13-Methyltetradec-4-enoic acid
|
FA 15:1
|
C15H28O2 |
240.208930
|
LMFA01060242
|
15Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,15Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4 |
394.308310
|
LMFA01060243
|
16Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,16Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4 |
394.308310
|
LMFA01060244
|
17Z-Insignoic acid A
|
6-hydroxy-4-oxotetracosa-2E,17Z-dienoic acid
|
FA 24:3;O2
|
C24H42O4 |
394.308310
|
LMFA01060245
|
15Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,15Z-trienoic acid
|
FA 24:4;O
|
C24H40O3 |
376.297745
|
LMFA01060246
|
16Z-Insignoic acid B
|
4-oxotetracosa-2E,5E,16Z-trienoic acid
|
FA 24:4;O
|
C24H40O3 |
376.297745
|